The primary objective is to show that the addition of osteopathic treatment to classical medical treatment decreases pain for patients with chronic nonspecific low back pain.
This goal will be evaluated at 3 months by comparing
* the 3-month change in the level of pain observed in arm 3 (classical medical treatment + osteopathic treatment) versus that observed in arm 1 (classical medical treatment), and
* the 3-month change in the level of pain observed in arm 3 (classical medical treatment + osteopathic treatment) versus that observed in arm 2 (classical medical treatment+ sham osteopathic treatment ).
Age
18–64
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient with chronic non-specific low back pain: degenerative lumbalgia and low back pain unrelated to anatomical lesions that have been evolving for more than 3 months.
Patient affiliated with a social security scheme or equivalent
Patient having signed the study informed consent form.
You may not be if
Patient with specific low back pain: patient with one of the following pathologies: degenerative neurological pathology; infectious pathology; fracture vertebral lesion less than 1 year; vertebral osteosynthesis material or canal narrowing.
Patient following a treatment of the Morphinic or Neuroleptic type.
Pregnant, breastfeeding or parturient woman
Patient participating in another clinical study
Protected patient: Major under some form of guardianship ; Hospitalized without consent
Clareo Health | Study of the Contribution of Osteopathic Treatment to Classic Medical Management in Patients With Chronic Low Back Pain
